Blog Full Right Sidebar

Corona Remedies’ Rs 655.37-crore IPO has seen strong demand, with overall subscription at 9.33 times by Day 2. The GMP of around Rs 270 suggests a potential listing near Rs 1,332. While the company shows robust growth, brand concentration, regional dependence, and supply-chain risks remain. Analysts, however, maintain a long-term “subscribe” view given its strong fundamentals and strategic positioning.Read More

NALCO awarded a 25-year Mine Developer and Operator (MDO) contract for the Pottangi Bauxite Mines to Dilip Buildcon at a base charge of Rs 423 per ton; both companies’ shares will be in focus. The project includes developing the mine, an Overland Conveyor Corridor (OLCC), and allied infrastructure. Dilip Buildcon secured the contract as the L-1 bidder.Read More

Shares of AU Small Finance Bank are set to remain in focus after the Ministry of Finance approved raising the foreign investment limit from 49% to 74%. The move allows greater foreign participation, enhancing capital-raising potential while ensuring regulatory compliance under FDI and FEMA rules. Shares closed 1.9% higher at Rs 971.10.Read More

India’s IPO market has achieved a historic milestone, surpassing 100 listings for the first time in 18 years. This surge has raised a record Rs 1.6 lakh crore. However, investors are experiencing lower listing-day returns, indicating a shift in market dynamics. The IPO pipeline remains strong with major companies preparing to go public, suggesting continued fundraising activity.Read More

Bullion started Wednesday on a strong note, with silver futures hitting a record Rs 1,90,374/kg and gold trading above Rs 1.30 lakh/10 grams. Globally, silver extended gains after crossing $60/oz for the first time, reaching $61.4797/oz, driven by speculative bets that the US Federal Reserve will announce a 25-bps rate cut at its Dec. 9–10 meeting.Read More